A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.
Den RB, Kamrava M, Sheng Z, Werner-Wasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, Glass J, Friedman DP, Green MR, Camphausen K, Dicker AP.
Den RB, et al.
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):321-8. doi: 10.1016/j.ijrobp.2012.04.017. Epub 2012 Jun 9.
Int J Radiat Oncol Biol Phys. 2013.
PMID: 22687197
Free PMC article.
Clinical Trial.